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a  b  s  t  r  a  c  t
Amphimas  pterocarpoides  Harms  (Leguminosae)  is  widely  used  traditionally  in  Central  and
West  Africa  for  the  treatment  of various  ailments.  However,  no  data  regarding  its  safety
have been  published  until  now. Thus,  the present  study  aimed  to  investigate  the potential
toxicity  of  the methanol  extract  of  the  stem  bark  of Amphimas  pterocarpoides  (AP)  in Wistar
rats  following  the  OECD  guidelines.  In acute  oral  toxicity,  female  rats  received  a single  dose
of 2000  mg/kg  of  AP and were  observed  for 14  days.  In subchronic  toxicity,  doses  of 150,
300,  600  mg/kg/day  of  AP  were  given  per os  to rats  (males  and  females)  for  28 days.  No
death  and  abnormal  behaviors  were  observed  in acute  toxicity  and  the  LD50 was  estimated
higher  than  5000  mg/kg.  In the  subchronic  study,  AP  induced  no signiﬁcant  variation  in body
weight  and relative  weight  of  organs,  whereas  a delayed  decrease  of  white  blood  cell count
and  granulocytes  was  observed.  Inconsistent  increase  of the  total  cholesterol/high  density
lipoprotein  was  observed  at 600  mg/kg  in  males.  Such  variation  (not  dose  dependent)  and
without biological  relevance  indicate  a  wide  margin  of  safety  for the  traditional  use  of  AP.
©  2014  Published  by  Elsevier  Ireland  Ltd.  This  is  an open  access  article  under  the  CC
BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).. IntroductionMedicinal plants remain the most used form of
reatment in most African villages. According to the
orld Health Organization, about 80% of the world
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icenses/by-nc-nd/3.0/).population, especially in developing countries, rely on tra-
ditional  medicine for their primary health care [1]. Besides
the  deﬁciency and the elevated cost of modern medicine
[2], the easy accessibility of herbal medicines and the belief
that  they are safe and harmless since they are natural and
have  been used for thousands of years account for this
gained popularity of traditional medicine and encourage
the public toward self-medication [3,4]. Though several
plants possess interesting pharmacological activities, the
article under the CC BY-NC-ND license (http://creativecommons.org/
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valorization of these medicinal plants is very often lim-
ited  due to the lack of written records about their safety
or  toxicity [5]. Therefore, the acute and subchronic toxi-
cological studies of Amphimas pterocarpoides were carried
out.
Amphimas pterocarpoides Harms (Leguminoseae) is a
sub-Saharan tree known by regional names such as
bokanga, edjip, edzui, lati or yaya, and is distributed in
Central  and West Africa. Various preparations of root
and  stem bark of this plant are used in traditional
medicine to treat dysenteria, anemia, hematuria, dysmen-
orrhoea, impotence, and to prevent spontaneous abortion
[6,7].  In previous studies, hydro-alcoholic and aqueous
extracts of the bark of Amphimas pterocarpoides dis-
played antioxidant and antianemia activities in vitro and
in  vivo, respectively [8,9]. Moreover, four isoﬂavonoids
namely amphiisoﬂavone, isoformononetin, 8-methoxy-
isoformononetin, and 6-methoxyisoformononetin with
antioxidant and antimicrobial activities were isolated from
the  dichloromethane–methanol (50:50 v/v) extract of the
root  bark of Amphimas pterocarpoides [10]. In our previous
report, we isolated 11 potential estrogenic isoﬂavonoids
from a methanol extract of the stem bark of this plant
[11]. Our ongoing investigation showed osteoprotective
properties of this extract at the dose of 150 mg/kg BW in
adult  ovariectomized Wistar rats. Despite the wide appli-
cation  of this plant in the folkloric medical practice and
its  methodical published activities, no reports on toxic-
ity  and safety proﬁle are yet available. Therefore, this
study has been designed aiming to evaluate the acute
and  subchronic oral toxicity of the methanol extract
of the stem bark of Amphimas pterocarpoides in Wistar
rats.
2.  Material and methods
2.1.  Plant material and extraction
The stem bark of Amphimas pterocarpoides were col-
lected at Mount Eloumdem, in the suburbs of Yaounde,
Center Region of Cameroon, on August 10th 2013
(8:00–9:00 am). The plant was identiﬁed and authenticated
by Mr.  Victor Nana, a botanist at the Cameroon National
Herbarium where a voucher specimen is deposited under
the  reference number 52563/HNC. After the drying and
pulverization process, 3 kg of the powder was  extracted
with 10 L of methanol of analytical grade (Merk, Darmstadt,
Germany) for a total duration of 1 week. The ﬁltration and
renewal  of methanol occurred every 2 days. The collected
solution was concentrated under reduced pressure at 40 ◦C
and  lyophilized to produce 60 g of extract (2% yield) called
AP.  The extract was kept at 2–8 ◦C and dissolved in distilled
water prior to administration. The administered volume
was  2 mL  per 100 g BW.
As  reported in our previous study, 20 isoﬂavonoids and
1  ﬂavonoid were identiﬁed in the methanol extract of the
stem  bark of Amphimas pterocarpoides using a UHPLC-LTQ
Orbitrap system, and 11 representative isoﬂavonoids were
further  isolated and structurally identiﬁed using 1 and 2D
NMR  techniques [11].Reports 1 (2014) 877–884
2.2.  Animals
Young Wistar rats, aged 8–10 weeks (acute toxicity)
and 5–6 weeks (subchronic study) obtained from the ani-
mal  house of the Laboratory of Animal Physiology of
the  University of Yaounde I, Cameroon, were used. They
were  maintained in standard conditions of temperature
(at around 25 ◦C), with approximately 12 h light/dark nat-
ural  illumination cycle and a relative humidity of 45–55%.
They  had free access to standard rat chow and tap water
ad  libitum. The guidelines of the Institutional Ethic Com-
mittee  of the Cameroon Ministry of Scientiﬁc Research and
Technological Innovation, which has adopted the guide-
lines  established by the European Union on Animal Care
(CEE  Council 86/609) were followed for all procedures.
2.3. Acute toxicity
The  acute oral toxicity test was performed using the
acute toxicity class method (ATC) in accordance with the
Organization for Economic Cooperation and Development
(OECD) guideline 423 adopted on December 17th, 2001
[12].  Based on a survey of tests done using the conven-
tional LD50 that pointed out that female rats are generally
more sensitive [13,14] and according to the OECD rec-
ommendation, female rats were used for this experiment.
Six healthy rats were allocated in two groups of 3 ani-
mals each. The ﬁrst group (Control) received distilled water
by  gavage whereas the second group received a single
dose of 2000 mg/kg BW of AP. Prior to administration, ani-
mals  were weighted, marked, and fasted overnight without
suppression of water. After dosing, food was withheld
for a further 3–4 h while animals were observed indi-
vidually during the ﬁrst 30 min  and then 2, 4, 6 h after
treatment. Thereafter, observations were made once daily
(5–10  min) for a total period of 14 days and the ani-
mals were weighed every 4 days. The experiment was
repeated with the same dose and same number of animals
according to the OECD ﬂow charts [12]. The observation
focused on mortality, changes in general behavior, skin,
eyes,  fur, and somatomotor activity. Attention was  directed
to  observations of tremors, convulsions, salivation, diar-
rhea,  lethargy, sleep, and coma. At the end of the 14th
day, animals were sacriﬁced by decapitation under light
anaesthesia (10 mg/kg BW diazepam and 50 mg/kg BW
ketamine i.p.) and liver, lungs, kidneys, heart, stomach,
spleen, and adrenals were removed, weighed and imme-
diately observed for gross pathological changes (gross
necropsy).
2.4.  Subchronic toxicity
The  repeated dose 28-day oral toxicity was carried
out according to OECD guideline 407, adopted on October
3rd,  2008 [15]. Sixty Wistar rats were distributed in 6
groups  of 10 animals each (5 females and 5 males). Ani-
mals  were segregated according to their gender to avoid
any  chance of mating. After a 7-day adaptation, the ani-
mals  were treated as follows: The ﬁrst group received
distilled water (Control); groups 2–4 received the AP
extract at the doses of 150, 300, and 600 mg/kg BW,





















































Fig. 1. Body weight evolution of rats treated orally with the methanol
extract of the stem bark of Amphimas pterocarpoides at the single dose of
Throughout the experiment, no mortality or treatment-
related signs of toxicity were recorded.
Table 1
Relative weight of organs (mg/kg BW)  in the control and AP-treated
(2000 mg/kg BW)  groups.
Organs Control 2000 mg/kg
Heart 3595 ± 79.0 3564 ± 107
Liver 34130 ± 126 31056 ± 976
Stomach 8473 ± 769 8068 ± 233
Lungs 6343 ± 40.0 6351 ± 739J. Tchoumtchoua et al. / Tox
espectively; Groups 5–6 served as satellite in the con-
rol  (Control SAT) and the top dose (600 SAT) groups,
espectively. Animals were treated daily (12:00–13:00) by
avage  for 28 days and observed once daily. The satellite
roups were followed-up for 14 days after the end of the
reatment for observation of reversibility, or persistence,
r delayed occurrence of toxic effects. The observation
ocused on mortality, changes in general behavior, skin,
yes,  fur, and somatomotor activity. Attention was directed
o  observations of tremors, convulsions, salivation, diar-
hea,  lethargy, sleep, and coma. Animals were weighed
very 4 days during treatment and posttreatment peri-
ds.  Twenty-four hours after the last administration (for
roups  1–4) and after the posttreatment follow-up (satel-
ite  groups), animals were sacriﬁced by decapitation under
ight  anaesthesia (10 mg/kg BW diazepam and 50 mg/kg
W  ketamine i.p.) after a 10–12 h overnight fast. Blood
amples were collected for hematological and biochemical
arameters analyses. The portion used for hematologi-
al analyses was collected in EDTA-coated tubes and the
emainder in dry tubes. The heart, liver, kidneys, stom-
ch,  spleen, adrenals, and lungs were dissected, weighed,
nd  immediately observed for gross pathological changes
gross  necropsy). Thereafter, liver, kidneys, and lungs were
xed  for 4 days in 10% formaldehyde for histological anal-
sis.
.5.  Measurement of hematological and biochemical
arameters
Blood samples in dry tubes were centrifuged at 3500 g
15  min  at 4 ◦C) and the supernatant (serum) was col-
ected and introduced into new tubes. Triglycerides (TG),
otal  cholesterol (TC), high density lipoprotein (HDL-C), ala-
ine  transaminase (ALT), and aspartate transaminase (AST)
ere  measured using reagent kits from Fortress Diagnos-
ics  Limited (Muckamore, United Kingdom) whereas the
otal  bilirubin (TB) concentration was determined using
eagent kits from Cypress Diagnostics (Langdorp, Belgium).
otal  proteins (TP) were measured using the Biuret reagent.
For  hematological analysis, white blood cell (WBC)
ount, lymphocytes, monocytes, granulocytes, red blood
ell  (RBC) count, hematocrit, hemoglobin, mean corpuscu-
ar  volume (MCV), mean corpuscular hemoglobin (MCH),
ean  corpuscular hemoglobin concentration (MCHC), and
latelets  count were evaluated using a HumaCount 30TS
utomated Hematology Analyzer from Human Diagnostics
orldwide (Wiesbaden, Germany).
.6. Histopathological examination of the liver and the
idney
Liver,  lung, and kidneys were dehydrated by a series of
thanol  solution and embedded in parafﬁn blocks before
utting into 5 m sections. These sections were stained
ith hematoxylin and eosin (HE) and examined under an
xioskop  40 microscope connected to a computer where
he  image was transferred using MRGrab1.0 and Axio
ision 3.1 softwares (Zeiss, Hallbermoos, Germany).2000  mg/kg BW.  Each point represents the mean ± SEM (n = 6). No signif-
icant difference.
2.7. Statistical analysis
Data  are expressed as mean ± standard error of the
mean (SEM). Comparison and analysis were performed
using the two way nonparametric Mann–Whitney U test
using  GraphPat InStat 3.05 statistical software. The results
were  considered to be signiﬁcant at values p < 0.05.
3. Results
3.1. Acute toxicity
The  single oral dose of AP at 2000 mg/kg BW,  even after
the  repetition of the experiment did not cause mortality,
changes in general behavior or any clinical signs of toxic-
ity.  In addition, between group signiﬁcant differences were
not  observed with respect to body weight proﬁle (Fig. 1),
relative  weight (Table 1), and gross pathological examina-
tions of the selected organs. According to the OECD ﬂow
chart  recommendations, the LD50 was  estimated greater
than 5000 mg/kg.
3.2. Subchronic toxicity
3.2.1.  ObservationsSpleen 2790 ± 262 2949 ± 314
Adrenals 483 ± 32.0 395 ± 43.0
Kidneys 6862 ± 74.0 6849 ± 495
Data are represented as mean ± SEM (n = 6). No signiﬁcant difference.
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Table 2
Relative organ weights after a 28-day treatment with the methanol extract of stem bark of Amphimas pterocarpoides in male Wistar rats.
Organs Control A. pterocarpoides (mg/kg BW)  Satellite groups
150 300 600 Control SAT 600 SAT
Liver 37820 ± 1870 36542 ± 1932 37418 ± 2057 37340 ± 1870 40944 ± 5610 34287 ± 383
Stomach  9497 ± 624 9526 ± 387 10320 ± 634 9815 ± 1004 8728 ± 1116 7920 ± 277
Kidneys  6495 ± 249 6185 ± 225 6895 ± 251 7873 ± 817 6636 ± 881 5993 ± 148
Lungs  7160 ± 842 8053 ± 712 6579 ± 487 7770 ± 969 6975 ± 1115 5096 ± 182
Spleen  4628 ± 718 5375 ± 849 5003 ± 635 6175 ± 1360 2789 ± 393 2897 ± 256
Heart  3511 ± 105 3588 ± 217 4034 ± 231 3772 ± 343 3472 ± 469 3245 ± 62
5 ± 29 254 ± 52 382 ± 73 346 ± 25
l treated with vehicle; 600 SAT: satellite of top dose treated with the extract at
Fig. 2. Body weight evolution of male (A) and female (B) rats during a 28-
day  treatment with the methanol extract of the stem bark of Amphimas
pterocarpoides at 150, 300, and 600 mg/kg BW (n = 5). Each point repre-Adrenals  264 ± 23 217 ± 15 23
Data are represented as mean ± SEM (n = 5). Control SAT: satellite contro
600  mg/kg BW.  No signiﬁcant difference.
3.2.2. Body and organ weights
Compared  to the control groups, no signiﬁcant differ-
ences were observed in the body weight evolution (Fig. 2)
or  relative organ weights (Tables 2 and 3) at all the tested
doses after the 28-day treatment and the 14-day posttreat-
ment observation.
3.2.3. Hematological parameters
Table 4 shows that the 28-day oral administration of
AP  (once daily) induced a signiﬁcant increase (p < 0.01) of
platelets  in males at the dose of 600 mg/kg. In addition, a
signiﬁcant and delayed decrease (p < 0.01) of white blood
cell  count (WBC), monocytes, granulocytes, and platelets
as  well as a signiﬁcant increase (p < 0.01) of lymphocytes
were noted in males after the 14-day posttreatment follow-
up.
In  females, signiﬁcant increases (p < 0.05) of RBC (at 150
and  600 mg/kg), along with hematocrit and hemoglobin (at
600  mg/kg) were observed. Moreover, signiﬁcant increases
(p  < 0.01) of platelets were noted at the doses of 300 and
600  mg/kg after the 28-day treatment, whereas signiﬁcant
and  delayed decreases of WBC  (p < 0.05), granulocytes, and
platelets  (p < 0.01) were observed after a 14-day posttreat-
ment (Table 5).
3.2.4.  Biochemical parameters
Table  6 shows a signiﬁcant decrease (p < 0.01) of HDL-
C  levels at all tested doses and a signiﬁcant increase
(p < 0.01) of total bilirubin (TB) at 600 mg/kg in males. No
signiﬁcant variations were observed in TG and TC lev-
els.  On the other hand, signiﬁcant increases (p < 0.05) of
the  TC/HDL-C ratio was observed at 150 mg/kg. Compared
sents the mean ± SEM. Control SAT: satellite control treated with vehicle;
600 mg/kg SAT: satellite of top dose treated with 600 mg/kg of extract. No
signiﬁcant difference.
Table 3
Relative organ weights after a 28-day treatment with the methanol extract of stem bark of Amphimas pterocarpoides in female Wistar rats.
Organs Control A. pterocarpoides (mg/kg BW)  Satellite groups
150 300 600 Control SAT 600 SAT
Liver 32243 ± 1577 34944 ± 1105 36330 ± 2318 32457 ± 726 31156 ± 1188 34523 ± 1177
Stomach  9417 ± 520 8335 ± 217 9141 ± 226 9001 ± 327 8172 ± 324 9915 ± 215
Kidneys  6651 ± 141 6676 ± 186 6374 ± 312 6663 ± 93 6231 ± 93 6213 ± 120
Lungs  8665 ± 983 8438 ± 575 7635 ± 616 8374 ± 1166 7262 ± 309 7489 ± 682
Spleen  5121 ± 680 3427 ± 624 3799 ± 631 3100 ± 396 3076 ± 103 4059 ± 173
Heart  3845 ± 158 4180 ± 149 3816 ± 201 3812 ± 201 3916 ± 191 3725 ± 179
Adrenals  386 ± 19 543 ± 83 438 ± 100 383 ± 33 406 ± 37 545 ± 21
Data are represented as mean ± SEM (n = 5). Control SAT: satellite control treated with vehicle; 600 SAT: satellite of top dose treated with the extract at
600  mg/kg BW.  No signiﬁcant difference.
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Table 4
Hematological parameters after a 28-day treatment with the methanol extract of stem bark of Amphimas pterocarpoides in male Wistar rats.
Parameters Historical ranges Control A. pterocarpoides (mg/kg BW)  Satellite groups
150 300 600 Control SAT 600 SAT
WBC  (×103 L−1) 5–16 15.58 ± 2.65 14.84 ± 2,18 15.96 ± 2.23 17.32 ± 4.78 13.38 ± 1.92 3.55 ± 0.35**
Lymphocytes (%) 65–85 68.58 ± 2.27 68.04 ± 2,85 64.30 ± 2.23 70.18 ± 1.42 76.78 ± 1.19 89.33 ± 1.26**
Monocytes (%) 0–20 19.66 ± 1.12 18.60 ± 1,18 20.96 ± 1.36 16.28 ± 1.27 14.10 ± 1.70 8.40 ± 0.45**
Granulocytes (%) 0–27 11.78 ± 1.33 13.38 ± 1,55 14.74 ± 1.46 13.54 ± 1.53 11.60 ± 0.76 2.48 ± 0.53**
RBC (×103 L−1) 5–10 7.30 ± 0.31 6.71 ± 0,88 7.53 ± 0.30 7.65 ± 1.21 7.00 ± 0.48 5.47 ± 0.48
Hematocrit  (%) 32–53 38.94 ± 1.26 35.66 ± 3,55 38.92 ± 1.33 39.82 ± 6.08 36.70 ± 4.46 27.03 ± 2.34
MCV  (fL) 52–59 53.40 ± 0.81 54.80 ± 2,85 51.60 ± 0.81 52.20 ± 1.32 57.25 ± 3.95 49.80 ± 0.48
Platelets  (×103 L−1) 200–1100 317.60 ± 23.26 266.80 ± 17,50 328.40 ± 15.07 419.60 ± 22.75** 271.00 ± 24,46 72.67 ± 4.06**
MCH  (pg) 17–27 18.88 ± 0.27 21.12 ± 2,86 18.18 ± 0.40 17.74 ± 0.61 24.02 ± 2.23 19.13 ± 0.18
Hemoglobin  (g/dL) 12–18 13.76 ± 0.48 13.16 ± 0,61 13.68 ± 0.48 13.68 ± 2.46 12.62 ± 1.49 10.40 ± 0.83
MCHC  (g/dL) 32–45 35.34 ± 0.34 38.02 ± 0,97 35.18 ± 0.97 34.00 ± 0.77 41.34 ± 0.84 38.53 ± 0.26
WBC: white blood cells; RBC: red blood cells; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; MCHM:  mean corpuscular hemoglobin
concentration.  Control SAT: satellite control treated with vehicle; 600 SAT: satellite of top dose treated with AP at 600 mg/kg BW.
Data  are represented as mean ± SEM (n = 5).
**p  < 0.01 signiﬁcantly different as compared to control groups.
Table 5
Hematological parameters after a 28-day treatment with the methanol extract of stem bark of Amphimas pterocarpoides in female Wistar rats.
Parameters Historical ranges Control A. pterocarpoides (mg/kg BW)  Satellite groups
150 300 600 Control SAT 600 SAT
WBC  (×103 L−1) 5–16 11.90 ± 0.42 11.40 ± 0.49 12.94 ± 1.78 9.18 ± 2.35 14.92 ± 2.71 6.84 ± 0.82*
Lymphocytes (%) 65–85 75.88 ± 1.25 70.55  ± 2.53 72.68 ± 1.39 73.70 ± 1.82 79.06 ± 2.88 82.18 ± 2.57
Monocytes  (%) 0–20 14.23 ± 0.70 14.98 ± 1.04 15.52 ± 0.88 16.46 ± 1.05 12.92 ± 0.59 11.80 ± 1.06
Granulocytes  (%) 0–27 11.03 ± 0.66 16.58 ± 2.54 11.50 ± 0.84 9.88 ± 1.03 12.18 ± 1.45 6.28 ± 0.77**
RBC (×103 L−1) 5–10 6.86 ± 0.33 8.18 ± 0.37* 7.47 ± 0.30 8.20 ± 0.21** 5.51 ± 0.68 5.74 ± 0.37
Hematocrit  (%) 32–53 37.22 ± 2.76 38.46 ± 3.97 40.50 ± 1.34 45.60 ± 1.30* 25.76 ± 3.98 28.16 ± 1.72
MCV  (fL) 52–59 58.00 ± 1.97 56.80 ± 4.72 54.40 ± 108 55.60 ± 1.20 54.60 ± 3.88 49.20 ± 0.20
Platelets  (×103 L−1) 200–1100 343.67 ± 9.39 390.33 ± 41.00 440.75 ± 41.02** 488.00 ± 26.82** 216.00 ± 82.47 105.00 ± 3.83**
MCH  (pg) 17–27 18.16  ± 0.26 17.03 ± 0.43 18.86 ± 0.49 18.12 ± 0.28 26.50 ± 3.26 19.56 ± 0.25
Hemoglobin  (g/dL) 12–18 12.90 ± 0.45 13.73 ± 0.80 14.04 ± 0.48 14.92 ± 0.32** 7.33 ± 1.51 11.26 ± 0.82
MCHC  (g/dL) 32–45 32.50 ± 0.17 33.57 ± 0.93 34.66 ± 0.51 32.74 ± 0.78 45.60 ± 2.57 39.76 ± 0.54














*oncentration.  Control SAT: satellite control treated with vehicle; 600 SA
ata  are represented as mean ± SEM (n = 5).
p  < 0.05 and **p < 0.01 signiﬁcantly different from control groups.
o the satellite control, the extract at the dose of
00 mg/kg induced a delayed and signiﬁcant decrease
p  < 0.01) of total proteins (TP) after a 14-day posttreat-
ent.
In females, all biochemical parameters evaluated were
ot  signiﬁcantly different (Table 7).
able 6
iochemical parameters after a 28-day treatment with the methanol extract of st
Parameters Control A. pterocarpoides (mg/kg BW)  
150 300 
TG (mg/dL) 95.92 ± 21.39 124.25 ± 9.14 79.64 ± 18.
TC  (mg/dL) 76.36 ± 4.63 73.40 ± 5.06 74.38 ± 5.3
HDL-C (mg/dL) 31.86 ± 2.39 24.78 ± 0.70** 22.36 ± 2.0
ALT  (U/L) 96.56 ± 6.64 93.23 ± 2.97 107.24 ± 4.5
AST  (U/L) 105.79 ± 6.39 106.54 ± 3.30 108.86 ± 1.2
TB  (mg/dL) 0.2 ± 0.02 0.19 ± 0.03 0.22 ± 0.0
TP  (g/dL) 1.39 ± 0.04 1.31  ± 0.02 1.35 ± 0.0
TC/HDL-C 2.43 ± 0.18 2.97 ± 0.24 3.44 ± 0.3
G: triglycerides; TC: total cholesterol; HDL-C: high density lipoprotein cholest
ilirubin;  TP: total protein. Control SAT: satellite control treated with vehicle; 60
ata are represented as mean ± SEM (n = 5).
p  < 0.05 and **p < 0.01 signiﬁcantly different compared to control groups.ite of top dose treated with AP at 600 mg/kg BW.
3.2.5. Histopathological assessment of the liver, kidney,
and lung
Compared to the control groups, histopathological fea-
tures  of the liver and the kidney of male and female
Wistar rats showed normal structures after a subchronic
(28 days) administration of AP at the doses of 150, 300, and
em bark of Amphimas pterocarpoides in male Wistar rats.
Satellite groups
600 Control SAT 600 SAT
85 69.73 ± 11.98 105.06 ± 15.80 103.47 ± 3.91
7 79.05 ± 9.19 77.13 ± 4.76 83.72 ± 13.04
3** 21.48 ± 2.27** 13.92 ± 0.98 15.21 ± 1.77
8 116.96 ± 4.58 111.20 ± 4.58 99.16 ± 4.91
6 115.91 ± 3.83 111.00 ± 2.92 108.67 ± 1.92
3 0.45 ± 0.11** 0.24 ± 0.02 0.24 ± 0.02
5 1.46 ± 0.07 1.43 ± 0.10 1.17 ± 0.02**
7 3.70 ± 0.24* 5.64 ± 0.47 5.45 ± 0.72
erol; ALT: alanine transaminase; AST: aspartate transaminase; TB: total
0 SAT: satellite of top dose treated with AP at 600 mg/kg BW.
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Table 7
Biochemical parameters after a 28-day treatment with the methanol extract of stem bark of Amphimas pterocarpoides in female Wistar rats.
Parameters Control A. pterocarpoides (mg/kg BW)  Satellite groups
150 300 600 Control SAT 600 SAT
TG (mg/dL) 68.65 ± 6.69 93.48 ± 4.96 92.96 ± 9.82 84.66 ± 8.72 66.64 ± 3.05 64.54 ± 8.00
TC  (mg/dL) 60.87 ± 3.84 61.09 ± 8.91 60.20 ± 7.49 54.01 ± 3.55 63.92 ± 10.71 67.61 ± 12.63
HDL-C  (mg/dL) 22.04 ± 1.19 18.80 ± 0.83 22.43 ± 1.37 22.33 ± 0.61 10.33 ± 0.87 10.71 ± 1.69
ALT  (U/L) 105.4 ± 1.29 100.13 ± 3.70 104.73 ± 3.13 101.80 ± 2.58 115.72 ± 1.86 106.87 ± 4.04
AST  (U/L) 121.2 ± 3.72 129.64 ± 5.71 114.34 ± 4.88 112.99 ± 2.98 108.46 ± 4.36 112.60 ± 3.93
TB  (mg/dL) 0.3  ± 0.02 0.3 ± 0.02 0.3 ± 0.02 0.34 ± 0.02 0.26 ± 0.02 0.29 ± 0.03
TP  (g/dL) 1.47  ± 0.05 1.52 ± 0.08 1.44 ± 0.05 1.48 ± 0.04 1.29 ± 0.07 1.07 ± 0.07
TC/HDL-C  2.78 ± 0.17 3.24 ± 0.45 2.71 ± 0.34 2.42 ± 0.13 6.71 ± 1.64 7.88 ± 3.01
TG: triglycerides; TC: total cholesterol; HDL-C: high density lipoprotein cholesterol; ALT: alanine transaminase; AST: aspartate transaminase; TB: total
bilirubin;  TP: total protein. Control SAT: satellite control treated with vehicle; 600 SAT: satellite of top dose treated with AP at 600 mg/kg BW.
Data are represented as mean ± SEM (n = 5).
*p  < 0.05 and **p < 0.01 signiﬁcantly different from control groups.
600 mg/kg. In males, a slight overdistention of air spaces
was  observed at the dose of 300 mg/kg (Fig. 3).
4.  Discussion
Amphimas pterocarpoides is a plant widely used in
African traditional medicine for the treatment of various
ailments. The present work evaluates the acute and sub-
chronic  oral toxicity of the methanol extract of stem bark
of  this plant (AP) in order to determine its safety proﬁle.
In  the acute toxicity study, neither mortality nor any signs
of  toxicity were observed in animals after the oral admin-
istration of AP at the dose of 2000 mg/kg BW and after
a  posttreatment period of 14 days. The results remained
the same even after the repetition of the experiment and
thus,  the LD50 has been estimated greater than 5000 mg/kg.
Such  substances, according to Kennedy et al. are considered
as  practically nontoxic and resulted in classifying of AP in
hazard  category 5 or unclassiﬁed in accordance with the
Globally  Harmonized Classiﬁcation System for Chemical
Substances and Mixtures [12,16,17].
In the 28-day treatment, no signiﬁcant differences in
the  relative weight of organs were noted compared to the
control  groups. Relative organ weight is an indicator of
toxic  effects of drugs [18], and any signiﬁcant increase of
relative  weight of the organs might be due to the hyper-
trophy and/or hyperplasia. In line with this, our results
suggest that at the tested doses, AP did not induce the
hypertrophy or hyperplasia in the selected organs. Sim-
ilarly,  the change in body weight may  be an important
signal of toxicity [19]. No statistically signiﬁcant differ-
ence  in body weight of animals was observed suggesting
that at the tested doses AP has no effect on animals’
growth.
The hematopoietic system is one of the most sensi-
tive targets of xenobiotics [20]. Therefore, it constitutes
an important marker of the physiopathological status [21]
and  provides informations on the vital state of the bone
marrow activity and on the intra-vascular effects of xeno-
biotics  [22]. Compared to the control group, signiﬁcant
increases in RBC count (at 150 and 600 mg/kg), hemat-
ocrit and hemoglobin (at 600 mg/kg) were noted in females.
Although these slight variations were statistically sig-
niﬁcant, they remained within the normal physiologicalranges [23] and therefore, cannot be considered as toxic
effects. These variations are not observed in males, sug-
gesting a higher sensitivity of females to the treatment.
Platelets play an important role in hemostasis through the
building  of a platelet plug. Our results showed a signif-
icant increase albeit in the normal physiological limits,
of  platelet count at 300 mg/kg in females and 600 mg/kg
in  both sexes. However, satellites groups of both sexes
treated with the top dose of extract (600 SAT) showed
a signiﬁcant decrease of platelet count compared to the
Control SAT group. These results suggest that AP at the
highest tested dose induced a delayed effect either by
decreasing platelets production or by reducing the cir-
culating levels of platelets (thrombocytopenia). Likewise,
there was a delayed decrease of white blood cells count
in  both sexes at the dose of 600 mg/kg probably due to
the  action of AP on hematopoietic cells and/or on cir-
culating white blood cells. On the other hand, delayed
decreases in monocytes (in males) and granulocytes (both
sexes)  as well as a delayed increase in lymphocytes (in
males)  were observed suggesting that AP acts in opposite
way  on leucocyte subpopulations and has gender-related
effects.
As far as biochemical parameters are concerned, the
subchronic administration of AP induced no signiﬁcant
variation of ALT and AST. ALT, speciﬁc to hepatocytes and
AST,  found in liver, cardiac muscle, and kidney [24,25] are
well-known as markers of cell damage, especially hepato-
cyte  necrosis [26,27]. Therefore, the non variation of these
two  parameters indicated the absence of hepatocyte necro-
sis.  Total bilirubin, product of hemoglobin degradation is a
marker  of hepatobiliary injury [28,29]. In our study, sub-
chronic  treatment with AP at the dose of 600 mg/kg induced
a  signiﬁcant increase of total bilirubin in males. Usually,
the  increase in serum bilirubin is related to an increase of
hemolysis  [30], liver injury or cholestasis [31]. Given the
lack  of any signs of necrosis following the histopathologi-
cal examinations of the liver, no signiﬁcant variation of ALT
activity  and RBC, the increase in total bilirubin observed
in  males not indicated any sign of toxicity since all values
were  within physiological ranges. Signiﬁcant decrease of
HDL-C  levels were observed in males at all the tested doses
while  no statistically signiﬁcant difference was  noted in
females,  suggesting a gender-related effect in which males





















(ig. 3. Microphotographs of hematoxylin/eosin (400×) stained sections 
mphimas  pterocarpoides at 150, 300, and 600 mg/kg. TSAT: satellite contr
t  600 mg/kg.
ere more sensitive. It has long been known that a low
DL-C  is a predictor of increased cardiovascular risk. How-
ver,  over the last decade, it appeared that these lipids’
arameters taken individually are not always reliable indi-
ators  of the cardiovascular disease [32]. Therefore, the
C/HDL-C ratio is thought to be more predictive for the
ardiovascular risks and its increase is correlated posi-
ively with the increase of cardiovascular risks. Increase
f  the TC/HDL-C ratio was only observed at the doses of
00  mg/kg in males. According to our results, the increase
f  TC/HDL-C appears to be mainly due to de decrease of
DL-C  observed.
Histopathological examinations of the liver and the kid-
ey  of both sexes showed normal integrity of these tissues
t  all tested doses after a subchronic treatment of AP.
owever, a slight increase of the volume of pulmonary
lveoli was noted in males at the dose of 300 mg/kg. Since
here  were no signs of lungs injury at the highest dose
600 mg/kg), this slight overdistention of alveoli air spaces in subchronic oral treatment with the methanol extract of stem bark of
d with the vehicle, SAT 600: Satellite of top dose treated with the extract
was  observed at 300 mg/kg appear to be an artifact or a
biological variation with a lack of biological signiﬁcance.
5. Conclusions
In conclusion, the single oral dose of 2000 mg/kg of
the  methanol extract of the stem bark of Amphimas pte-
rocarpoides induced no mortality, no behavior changes,
and any treatment-related signs of toxicity. However, in
subchronic treatment, AP induced a delayed decrease of
white  blood cell and platelet count at 600 mg/kg. Therefore,
the  present investigation demonstrated that the methanol
extract of stem bark of Amphimas pterocarpoides may be
considered as relatively safe of toxicity. As the extract used
differs  from the traditional preparation (usually decoc-
tion), this could account for the inconsistent adverse effects
observed. Therefore, further studies with the traditional
way of preparation are needed to extrapolate the safety
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